Clicky

Ckd Bio(063160)

Description: CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, ß-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The company also provides contract research and development, and manufacturing services for active pharmaceutical ingredients and intermediates, and probiotics. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.


Keywords: Biotechnology Medication Antibiotics Active Pharmaceutical Ingredients Obesity Probiotic Obesity Treatment Drug Substances

Home Page: www.ckdbio.com

CKD building
Seoul, 03742
South Korea
Phone: 82 2 2194 0555


Officers

Name Title
Mr. Jang-Han Lee Joint Chief Exec. Officer
Mr. Hui Yil Kang Co-Chief Exec. Officer, VP and Director
Mr. Tae-Won Kang Managing Director
Mr. Young Tae Kim Managing Director

Exchange: KO

Country: KR

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.9151
Price-to-Sales TTM: 0.9185
IPO Date:
Fiscal Year End: December
Full Time Employees: 555
Back to stocks